Lecia V. Sequist on Side Effects From Agents for Resistant Lung Cancer
Lecia V. Sequist, discusses the adverse event profiles of rociletinib (CO-1686) and osimertinib (AZD9291).
Read More
Lecia V. Sequist Provides an Overview of T790M Mutations in NSCLC
Lecia V. Sequist, associate professor of medicine, Massachusetts General Hospital, provides an overview of T790M, a mutation in the epidermal growth factor receptor (EGFR) gene.